Central nervous system acting medication used by young adults with borderline personality disorder in Sweden 2006–2019
This indicates the importance of continuously evaluating risks and benefits with medication use, and in having easy access to up-to-date guidance about best clinical practice for individuals diagnosed with BPD, to facilitate appropriate and safe medication use.
Authors
- Clara Hellner (ORCID: https://orcid.org/0000-0002-8375-9447)
- Annika Tiger
- Tyra Lagerberg (ORCID: https://orcid.org/0000-0003-2480-0216)
- Brian Matthew D'Onofrio (ORCID: https://orcid.org/0000-0002-5248-7434)
- Ralf Kuja-Halkola
- Y. Molero
- P. Lichtenstein
- Z. Chang
- Isabell Brikell (ORCID: https://orcid.org/0000-0002-3800-6665)
- Nitya Jayaram-Lindstrom
Institutions
- Aarhus University (DK)
- Örebro University (SE)
- Warneford Hospital (GB)
- Karolinska Institutet (SE)
- University of Oxford (GB)
- Indiana University Bloomington (US)
- Stockholm Health Care Services (SE)
- University of Bergen (NO)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1177/02698811251413479
- Primary Topic
- Personality Disorders and Psychopathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00